i-SEP - the alternative to allogeneic blood transfusions

i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .
i-SEP has developed and patented an innovative technology for the separation of blood components.

Technology

01

same™

i-SEP is developing a new generation of intraoperative cell salvage technology (IOCS) for use in hemorrhagic or high-risk hemorrhagic surgery, capable of recovering not only red blood cells but also the patient's platelets.

Events & news

Chronicle

08.10.19

Radio: i-SEP interview by Europe 1 radio show (“innovation of the day”)

Surgery: the auto-transfusion of patients will soon be possible during operations. A French innovation to overcome platelet shortages and minimize the risks of conventional transfusions. The blood lost by the…

Event

28.07.21

SFAR 2021 Congress september 23rd-25th, Paris Palais des Congrès Paris, Porte Maillot

[EVENT] Meet us and discover our unique autotransfusion technology in the exhibition area of the #SFAR2021 booth F3, from September 23 to 25 in Paris. #PatientBloodManagement#SFAR#autotransfusion#BPIFrance

News

28.05.21

Promising preclinical results for patients and physicians published in the prestigious journal Anesthesiology

Innovative medical device same™ by i-SEP: The publication of the preclinical results obtained in recent months in collaboration with academic and hospital partners, including the University Hospital of Rennes and Bordeaux,…

All news

Expertise :
autotransfusion,
the alternative
to allogenic
transfusions

Learn more

Innovative solutions & efficiency for the patient

Technology

Events & news

Download a
press release